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Abstract
Background: Despite the overwhelming evidence confirming the morbidity and mortality benefits of early initiation of
highly active anti-retroviral therapy (HAART) in HIV-infected infants, some children are still disadvantaged from gaining
access to care. The understanding of the maternal perspective on early infant HIV diagnosis and prompt initiation of
HAART has not been adequately explored, especially in the rural communities of South Africa. This study explores the
perspectives of mothers of HIV-exposed infants with regard to early infant diagnosis (EID) through a lens of social and
structural barriers to accessing primary healthcare in OR Tambo district, Eastern Cape Province, South Africa.
Methods: In this qualitative study, we conducted semi-structured interviews at two primary healthcare centres in the
King Sabata Dalindyebo Municipality of the OR Tambo district, South Africa. Twenty-four purposive sample of mothers
of HIV-exposed infants took part in the study. Interviews were tape-recorded, transcribed and field notes were obtained.
The findings were triangulated with two focus group discussions in order to enrich and validate the qualitative data.
Thematic content analysis was employed to analyse the data.
Results: The participants have fairly good knowledge of mother-to-child transmission of HIV and the risks during
pregnancy, delivery and breastfeeding. The majority of participants were confident of the protection offered
by anti-retroviral drugs provided during pregnancy, however, lack knowledge of optimal time for early infant
diagnosis of HIV. Reasons for not accessing EID included fear of finding out that their child is HIV positive,
feelings of guilt and/or shame and embarrassment with respect to raising an HIV infected infant. Personal
experiences of HIV diagnosis and HAART were associated with participants’ attitudes and beliefs toward care-seeking
behaviours. Stigma resulting from their own disclosure to others reduced their likelihood of recommending EID to
other members of their communities.
Conclusion: Despite the good knowledge of mothers about infant HIV infection and the availability of treatment, the
knowledge of the optimal time for early infant diagnosis is lacking. Fear of infant HIV diagnosis and stigma are challenges
for universal coverage of early infant diagnosis in these rural communities. Hence, community education and intensive
counselling of pregnant women about early infant diagnosis are urgently needed.
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Background
Mother-to-child transmission (MTCT) of HIV is one of
the major challenges of the HIV epidemic in the world
and especially, Sub-Saharan Africa [1, 2]. Despite the sig-
nificant progress made in reducing the rate of mother-to-
child transmission (MTCT) of HIV worldwide with varia-
tions across the countries [3], children accounted for
260,000 new HIV infections in 2012. The majority of these
new infections occurred in the Sub-Saharan African coun-
tries [3]. There is high morbidity and mortality associated
with untreated infant HIV infections [4–6]. Without ART,
52 % of the perinatally infected infants and 26 % of post-
natally infected infants will die within 12 months [7].
Many studies have demonstrated unequivocally, the im-
munologic, virologic and clinical benefits of early initiation
of HAARTS in infants [6, 8–12], providing overwhelming
evidences for the WHO’s recommendations on the early
diagnosis of HIV in infants [13]. The polymerase chain re-
action (PCR), which targets the DNA of the HIV for posi-
tive reaction has been rolled out worldwide for diagnosis
of HIV in children from birth to 18 months [14–16]. Ef-
fective paediatric HIV treatment starts with early diagno-
sis, prompt initiation of HAART, and frequent monitoring
to ensure retention and quality of care [17]. EID provides
the HIV-exposed infants with the opportunity to receive
early clinical evaluation, prophylaxis for opportunistic in-
fections and HAART [14, 16].
The major challenge facing EID services in the SSA
countries is the significant rate of loss to follow up of
mother-baby pair postnatally [17–22]. There is a wide
variation in the completion rate (Fig. 1) from HIV testing,
initiation of HAART and retention in care in African
countries [17]. Report from Tanzania indicated that 88 %
of infants were tested across three districts; among the in-
fants diagnosed with HIV infection, only 69 % were en-
rolled in care and 39% initiated on HAART were retained
in care [18]. Similar trends were observed at a tertiary hos-
pital in South Africa, where 72 % of 838 HIV-exposed in-
fants were tested, and only 67 % of the mothers returned
for the results. Among the 38 infants diagnosed with HIV,
61 % received HAART, and only 34 % were retained in
care at 68 weeks [21]. Hassan et al. (2012) in South Africa
reported three-quarter of mothers dropped out of care be-
fore six months after delivery and 85 % by the twelfth
month of follow up [6]. Additionally, other studies from
South Africa have also, indicated poor completion rates
from identification and testing of HIV-exposed infants,
maternal return rate for collection of results and linkage
of infected infants to care [23, 24].
EID services faces a number of programmatic chal-
lenges in Africa; migratory patterns of mothers after de-
livery [17]), fear of disclosure of maternal status and
possible stigmatization, lack of maternal understanding
of the benefits of enrolling infants in care, long waiting
times at clinics and lack of transportation [25]. Stigma
has been reported as a major barrier to HIV testing
across Africa [26–29]. Health systems’ factors such as
lack of coordination of care across HIV services resulted
in delays between HIV testing, post-test counselling, and
ART initiation [17].
The EID reports in South Africa, has shown that the
national coverage for total PCR testing is 53.5 % (range
40.6 %-71.5 %), which is below the number expected
based on antenatal HIV prevalence and live births [30].
Numerous challenges impacting on the uptake of EID
were irregular /slow communication of new policy up-
dates to relevant managers and health care workers, lack
of refresher/onsite trainings, staff shortages, dried blood
spot (DBS) kit supply interruption and poor DBS kit
stock control [31].
The district health barometer for 2011/2012 indicated
that OR Tambo district of Eastern Cape Province, South
Africa had performed poorly in EID services [32]. The ac-
cess of the HIV-exposed infants to the EID is dependent
on the health-seeking behaviour of the mothers whose
overall knowledge of the rationale and benefits of EID is
the determining factor. The knowledge and attitudes of
mothers toward knowing the HIV status of the child,
and the willingness to accept the result warrant inves-
tigation. The valuable input from the mothers could
inform future programmatic strategies for expanding
access to EID in the country. The aim of the present
study is to explore the perspectives and attitude of
mothers towards knowing the status of their HIV-
exposed infants as early as six weeks after delivery.
Methods
Setting
The study was conducted at two immunization clinics
(Ngangeliswe and Mbekweni) chosen randomly among
Fig. 1 Cascade of EID Services
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the primary healthcare centres in King Sabata Dalindyebo
Local Municipality, OR Tambo district of Eastern Cape
Province, South Africa. Ngangeliswe health centre delivers
approximately one hundred and fifty babies per month
with maternal HIV prevalence of 30.1 % (Unpublished
local statistics, 2012). Mbekweni health centre has a large
immunization clinic (average of three hundred babies per
month) with similar maternal HIV prevalence. The two
primary healthcare centres are located in the rural com-
munities outside of Mthatha, providing healthcare services
to people living in the deep rural communities of King
Sabata Dalindyebo Local Municipality, Eastern Cape
Province, South Africa. These health facilities have
Nurse Initiated Management of Anti-Retroviral Therapy
(NIMART) trained nurses, lay counsellors and visiting
doctors, who provide care for patients with HIV at the
centres. Despite the availability of EID services in both
centres, the return rate for six-week PCR result was low
(Unpublished local statistics, 2012).
Design
In order to explore the maternal knowledge, concerns,
fears, perceptions and attitude towards diagnosis of HIV
in an infant of six weeks old, a qualitative study using
semi-structure interviews, which allowed probing ques-
tions to clarify responses from participants, was consid-
ered the most appropriate design. In addition, focus
group discussions were held to enrich the qualitative
data, validate the findings from the interviews and to en-
sure group dynamics.
Ethical approval
Ethical approval was obtained from the University of
Stellenbosch Ethics Committee. The King Sabata
Dalindyebo Local Municipality manager and the clinic
managers of both primary healthcare centres gave permis-
sion for the study.
Recruitment
Recruitment of the participants took place in September
and October 2012. Participants were mothers whose in-
fants had missed PCR test at six weeks (EID). Eligibility cri-
teria were participants aged 18 years and above, had been
diagnosed with HIV infection and have HIV-exposed in-
fants less than 6 months old at the time of the study. One
of the nurses at the immunization clinics purposively se-
lected critical-case (mothers of infants who had missed the
six week PCR screening) sample of eligible mothers. The
objectives and methods of the study were explained to all
the participants who were approached. Mothers who
agreed to participate were asked to sign informed consent
before the interview.
Interview process
Semi-structure interviews with prompts were utilised to
obtain qualitative data from each participant. A trained
interviewer used open-ended techniques to elicit in-
depth information from the participants. Each interview
sessions lasted between 45 – 60 minutes. A pre-piloted
interview schedule was used to ensure that the key ques-
tions were asked if they did not arise spontaneously. The
interviews were conducted in the local language of the
participants (isiXhosa) to ensure that participants were
free and confident in their responses. The interviews were
audiotaped and the notes kept.
The following knowledge and attitude toward infant HIV
diagnosis were explored: mode of acquisition of HIV infec-
tion by infants, prevention of infant infections, and optimal
time of screening for HIV in infants, concerns about infant
with HIV infections, willingness and to test their infants.
Recruitment and interim analysis were conducted after
every five participants until no new information emerged
during the interviews (data saturation). The results of the
individual interviews were then triangulated with two focus
group discussions. Eight eligible mothers from each centre
participated in the focus groups. Varied individuals includ-
ing those whose infants have been tested for HIV and those
who were yet to test took part in the focus group discus-
sions. The discussions were tape-recorded and field notes
were taken during the sessions.
Data analysis
The audiotaped interviews were transcribed and translated
verbatim by two independent qualitative researchers. Notes
were then compared to ensure accuracy of transcription
and translation. Field notes were reviewed for additional
information. Thematic analysis technique was used for
data analysis. Line numbers were used to identify ques-
tions asked by the interviewer and responses made by
the participants. Themes were developed from the par-
ticipants’ responses on different questions and various is-
sues. Participants’ responses were categorised according
to themes. Themes were colour-coded and those colours
were used to shade any response relating to specific
themes in the interviews. Content theme analysis was
employed to maximise the chance that all relevant infor-
mation was grouped and coded appropriately. The notes
were cross checked to ensure appropriate responses of
participants.
Data credibility
One of the authors experienced in qualitative study, in-
dependently reviewed a random sample of six interviews
(including audiotapes, field notes and coding of themes)
and provided feedback on the overall trustworthiness of
the data and the analysis.
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Results
Characteristics of the participants
Table 1 presents the socio-demographic characteristics of
the participants according to age, level of education, marital
status, employment status, total number of children (alive
or dead), duration of HIV diagnosis and whether already
on HAART or not. All the participants were unemployed
except one participant in the individual interview. One
source of their income was the child grants from the de-
partment of social services.
Themes
The following themes and sub-themes emerged from the
analysis (Table 2).
(1) Knowledge of infant HIV infection, (2) methods of
prevention of infant HIV infection (3) HIV diagnosis (4)
Effects of untreated HIV infection in infants (5) willingness
and fears towards infant HIV testing, (6) expectations dur-
ing waiting period and coming for results, (7) infant
mandatory testing, and (8) suggestions of infant HIV test
to other mothers.
What do you know about HIV infection in infants?
The majority of the participants demonstrated good
knowledge of infant HIV infection.
‘The infant can be infected if the mother is HIV positive
and has not been tested’ (Ngangeliswe, 19, not on
HAART, Individual interview).
“If the mother does not use pills before giving birth, the
new born baby might be infected” (Mbekweni, 24, already
on HAART, Individual interview).
Some participants had misconceptions about the mode
of transmission of HIV to infants.
‘An infant is infected with HIV during birth if the mother
gave birth through operation since there is a lot of blood
involved’ (Mbekweni, 32, already on HAART, Focus
group)
“Touching the child by an HIV positive individual
might infect the child” (Ngangeliswe, 21, not on
HAART, Focus group)
Nearly all the participants were in agreement about
the risk of transmission during the time of delivery.
“Infection happens during delivery since there is lot of
blood. Also, through the blood which oozes during
birth” (Mbekweni, 28, already on HAART, Individual
interview)
Few participants were aware of the risk of HIV trans-
mission during pregnancy but had some misconceptions.
‘The unborn child is likely to be infected since he/she
shares everything with the mother’ (Ngangeliswe, 22,
already on HAART, individual interview).
Few participants were aware of the risks of HIV trans-
mission from breast milk and the associated factors.
‘Breastfeeding the child when you are HIV positive can
lead to transmission, but are not sure of the facts’
(Ngangeliswe, 34, not on HAART, Focus group).
“Exceeding six months when breastfeeding the infant
can lead to infection” (Mbekweni, 33, already on
HAART, Individual interview)








18–22 2 (8 %) 2 (12 %)
23–27 6 (25 %) 6 (38 %)
28–32 11 (46 %) 7 (44 %)
>32 5 (21 %) 1 (6 %)
Marital status
Single 14 (58 %) 10 (63 %)
Married 10 (42 %) 6 (37 %)
Level of education
< Grade 6 1 (4 %) -
Grade 6–9 16 (67 %) 5 (31 %)
Grade 10–12 5 (21 %) 11 (69 %)
Tertiary 2 (8 %) -
Employment status
Employed 1 (4 %) -
Unemployed 23 (96 %) 16 (100 %)
Total number of children (alive or dead)
1 7 (29 %) 8 (50 %)
2 7 (29 %) 5 (31 %)
3 or more 10 (42 %) 3 (19 %)
Duration of HIV diagnosis (years)
<1 9 (38 %) 2 (12 %)
1–3 7 (29 %) 11 (69 %)
>3 10 (33 %) 3 (19 %)
Currently on HAART
Yes 14 (58 %) 9 (56 %)
No 10 (42 %) 7 (44 %)
HAART highly active antiretroviral therapy
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Majority of the participants considered mixed feeding
as dangerous to the health of the child.
‘The mothers must choose between breastfeeding or
formula milk and not both’ (Mbekweni, 26, not on
HAART, Focus group)
“The mother should breastfeed for six months and after
that the baby can receive other foods. No water and other
foods in the first six months of the child” (Ngangeliswe,
32, Already on HAART, Individual interview)
Few individuals demonstrated fair knowledge of win-
dow period, which may give false hope that they were
negative and could later infect the baby.
‘The unborn baby is also infected as a result of the
window period since the mother thinks she is negative’
(Mbekweni, 20, Not on HAART, Individual interview)
There was an awareness of low CD4 count as an im-
portant risk factor in MTCT.
‘If the CD4 count of the mother is very low, the child’s
chances of infection are increased’ (Ngangeliswe, 32,
Already on HAART, Individual interview)
How could you prevent mother-to-child transmission of HIV?
The majority of the participants supported that women
should be initiated on HAART early in pregnancy.
Table 2 Summary of themes and sub-themes
Themes Sub-themes
What do you know about HIV infection in infants? Infection in mother can be transmitted to the child
Time of infection during pregnancy, delivery and breastfeeding
Window period in mother
Other contributory factors of MTCT: low CD4 count, mixed feeding,
prolonged breast feeding,
HAART initiation in mothers
How could you prevent MTCT of HIV? Time of initiation of HAART in pregnancy
Adherence to treatment
Probable risk of transmission despite HAART
Where could you obtain the infant test and when should you take your
child for the test?
Time of the test
Where the service is provided
Time of HAART initiation in infants





Would you like to have HIV test on your child? Willingness to test
Readiness to test
Reactions to HIV test in their children
DO you have any fears about HIV test in your child? Reasons for fear:
What are your expectations over the waiting period for the result? Embarrassment of having a child infected with HIV
What people in the community might say
Child might depend on medications to live
Child might be falling sick
Child might die
Reactions towards positive results
Confirmation of return date and willingness to collect results
Should HIV test be mandatory in the community Benefits to other children
Recommend HIV test to other children in your community
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‘When the mother is not treated early, the unborn baby
can be infected’ (Ngangeliswe, 22, already on HAART,
individual interview)
Some participants understood that failure to adhere to
ARVs is a risk for MTCT;
“If the mother does not take treatment while being HIV
positive, the infant can be infected’. If the mother starts
visiting the clinic late, the infant can be infected”
(Mbekweni, 28, already on HAART, Individual interview)
The majority of the participants understood that pro-
tecting the mother from HIV infection is crucial to pre-
vention of infant HIV infection.
‘Parents should use condom, wear gloves when helping
people in a car accident’ (Mbekweni, 24, Not on
HAART, Focus group)
Some participants demonstrated gaps in knowledge
about ways to prevent infant HIV infection.
“She knows nothing about infant infection prevention
since she never got any lesson on this” (Ngangeliswe,
33, Not on HAART, Individual interview)
There were some misconceptions demonstrated by the
participants about ways to prevent infant HIV infection.
“The child should avoid contact with other kids,
there should be no sharing of children’s toothbrush”
(Ngangeliswe, 19, not on HAART, Individual interview)
Where can you get the HIV test and when should your child
be tested?
Nearly all the participants knew that the HIV test (PCR)
is offered at the clinics.
‘We can only know the baby’s status after taking him
or her to the clinic’ (Mbekweni, 24, already on HAART,
Individual interview)
Few participants knew that their babies should be
tested at six weeks. However, there were variations in
the times suggested by the rest of the participants.
“The right time for the child is unknown. The child can
be diagnosed at any time” (Ngangeliswe, 32, Already on
HAART, Individual interview)
Nearly all the participants did not know how soon or
the right time for ARVs to be initiated in an infant with
HIV infection.
‘She doesn’t know the time of commencing ARVs, but
she prefers when the child is ready’ (Mbekweni, 24,
already on HAART, Individual interview)
What are the symptoms of HIV infection in untreated infants?
All the participants were familiar with the symptoms of
HIV infection in infants.
“They develop rash and wounds all over the mouth
and body. They usually have diarrhoea and loses
energy” (Mbekweni, 24, Not on HAART, Focus group).
Some participants reported the effect of untreated HIV
infection in infants could lead to paralysis and mental dis-
turbance. The majority of the participants knew that HIV
infected infant has increased vulnerability to infections
and myriads of disease conditions.
“S/he develops TB and big tummy, as well as weight loss.
Skin problems are possible with high body temperature”
(Ngangeliswe, 33, Not on HAART, Individual interview)
All the participants have witnessed and understood
that HIV infected child can die prematurely.
Attitude towards Early Infant HIV Diagnosis (EID)
Would you rather test your child for HIV now or later?
The majority of the participants never thought of bring-
ing their babies to the clinic for HIV test.
“She feels that her baby is too young to be tested”
(Mbekweni, 24, already on HAART, Individual interview)
“She never thought of bringing the child to the clinic for
HIV test because she was scared of injection for the little
one” ((Ngangeliswe, 21, not on HAART, Focus group)
Some of the participants who were willing to have
HIV test done for their children were not prepared to do
the test same day. One of the participants burst into
tears when asked about her readiness for HIV test in her
two-month-old boy.
“She is not willing because the child looks HIV negative”
(Ngangeliswe, 32, Already on HAART, Individual
interview)
Minority of the participants were ready to have HIV
test on their infant same day.
‘She wishes to see her child tested since she wants her
child to grow like other kids and she suspects that the
child might be positive” (Ngangeliswe, 22, already on
HAART, individual interview)
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Do you have any fears about EID for your baby?
Nearly all the participants have fears about HIV test in
their babies. They were worried that the result of the test
might be positive. Several reasons were provided for
their fears: embarrassment of having an HIV positive in-
fants, fear of what people might say, fear that the child will
depend on pills, fear of the child falling sick, fear that the
child might die and fear of how she would manage to live
with HIV positive child.
There were varied reactions towards the probable posi-
tive result of their infants: the majority of the participants
demonstrated feeling of guilt, while some were crying and
blaming themselves.
“If the child is positive, she would be reaping what she
sowed” (Mbekweni, 24, Not on HAART, Focus group)
Few expressed numb feelings toward a positive PCR
result.
What are your expectations over the next few days while
waiting for PCR result?
Nearly all the participants accepted that there are only
two possibilities from the result (either positive or nega-
tive). The majority of the participants demonstrated the
tendency to believe that the results would be positive
while only few expected a negative result.
‘She expected negative and positive and wishes for the
negative since she had done all that the nurses said
she should do’ (Mbekweni, 24, already on HAART,
Individual interview)
Participants expressed varied reactions towards waiting
for results of PCR.
“She will feel destroyed and nervous as she will ask
herself many questions. She will not even sleep at
night since her baby is too young to be positive”
(Mbekweni, 32, already on HAART, Focus group)
The majority of the participants confirmed that they
would return for the result on the appointment date.
However, few participants doubted if they have the cour-
age to return for the result.
‘She will come for the result on the said date since she is
curious’ (Ngangeliswe, 21, not on HAART, Focus group)
Should early infant HIV be mandatory at immunization
clinics?
The attitude to mandatory HIV test at six-week
immunization clinics was elicited from the participants
to assess the acceptability of EID. Nearly all the
participant agreed that infant mandatory HIV test is
beneficial to the child and parent.
“This will help the parents so that they cannot take
the child to where he shouldn’t be (traditional healer)’
(Ngangeliswe, 21, not on HAART, Focus group)
Would you recommend EID to other children in your
community?
The majority of the participants were cautious about
recommending infant HIV test to other children in their
community.
‘Yes, since there are many mothers who do HIV test
and choose not to take the results and their babies are
having health problems now’ (Mbekweni, 24, already
on HAART, Individual interview)
Some participants were not keen to recommend the
test to other children in their communities
‘It is not an easy thing when you stay in the rural
areas, because they think that you imply that their
kids are HIV positive’ (Mbekweni, 24, Not on HAART,
Focus group)
“I can’t do that because it requires that a person first
discloses her HIV status” (Ngangeliswe, 21, not on
HAART, Focus group)
Some participants suggested that education on early in-
fant diagnosis should be provided during antenatal period.
Discussion
The present study found high level of awareness of
mother-to-child transmission (MTCT) of HIV among
the participants. The participants understood that
MTCT of HIV occurs during pregnancy, delivery and
breastfeeding. Previous studies reported high level of
awareness about infant HIV infection in Ghana and
Ethiopia, respectively [33, 34]. This finding further con-
firmed the effectiveness of task shifting of HIV care from
doctors to nurses [35]. The NIMART initiative was intro-
duced in South Africa to support the de-centralisation of
HIV care to the primary healthcare facilities [36, 37].
NIMART trained nurses provide education on PMTCT at
the setting of this study. Though, not all mothers knew the
significance of the window period in relation to the risk of
MTCT. This is an important phenomenon in the viral
kinetics, which could pose a challenge to elimination
of mother-to-child HIV transmission. The South African
Guideline emphasise repeat of HIV test at 34 weeks dur-
ing pregnancy [16] in order to identify those that may
have sero-converted during pregnancy. HIV test at the
Adeniyi et al. BMC Pediatrics  (2015) 15:98 Page 7 of 10
time of delivery and at post-natal clinics could provide an-
swers on sero-conversion during late pregnancy and dur-
ing breast-feeding period.
WHO (2010) and South African National Department
of Health (2013) recommended HAART initiation in all
pregnant women either as prophylaxis or for maternal
health [13, 16]. The risk of MTCT is effectively reduced
among women initiated on HAART [38, 39]. The study
participants were aware of the benefit of ART in the pre-
vention of MTCT. Lazarus et al. (2009) reported that
mothers believed that Nevirapine prophylaxis guaranteed
protection against MTCT [40]. However, some participants
were not aware of the risk of MTCT despite the use of
ARVs. The beneficial effect of HAART in PMTCT is asso-
ciated with good adherence and viral suppression [41, 42].
Besides the ART, certain pregnancy-related factors, infant
factors and obstetric factors are associated with increased
risk of HIV transmissions: prolonged spontaneous rupture
of membrane, artificial rupture of membrane, episiotomy,
prematurity and breastfeeding [43, 44]. Future cohort stud-
ies should provide answers on the rate and time of infec-
tion in infants whose mothers were exposed to HAART.
Some participants reported non-adherence to ART as
an explanation for infant HIV infection despite ART in
mothers. There were still knowledge gaps among the
study participants on the various aspects of PMTCT and
infant diagnosis, which could be improved with integra-
tion of PMTCT/EID training during antenatal period.
The majority of the participants were not certain about
six-week EID services and early initiation of ART in
HIV-infected infants. However, most of the participants
desired to know more about HIV in infants. Hassan
et al. (2012) reported that the service providers did not
adequately cover EID during the antenatal and PMTCT
training [6]. The participants had inadequate knowledge
on early infant diagnosis, which is an expected finding.
The shortage of NIMART trained nurses and the large
number of patients managed by the few hands available
at the rural community clinics in this setting could offer
plausible explanation for the observed phenomenon.
Personal experience of living with HIV and stigma from
community members were some of the reasons for fear of
EID among the participants, hence, impact on the access
to the service at the clinics. Stigma-related to HIV/AIDS
include derogatory attitudes, beliefs and behaviours di-
rected toward people living with the disease [45, 46] affect
access to HIV testing and enrolment in care. Nearly all
the participants knew that the results could either be posi-
tive or negative though they tend to hope that the result
would be negative. Lazarus et al. (2009) reported, “I told
myself that just like in soccer, I should prepare myself to
either win or lose, positive or negative” [40].
The mention of positive result generated mixed reac-
tions from the participants; numbness, guilt, self-blame
and cries. This is similar to the findings of Lazarus et al.
2009 [40], which reported that mothers go through men-
tal preparedness to receive the results. ‘The HIV positive
infants’ mothers were ‘badly affected, upset, disappointed,
really hurt, feeling sad or bad………..’. In this study, major-
ity of the participants have not thought about HIV test in
their children despite missing the six-week PCR schedule.
This could be attributed to unresolved acceptance of EID.
Similar trend was reported in Cote d’Ivoire where mothers
moderately accepted the principle of EID and fathers’ level
of acceptance was low [47].
The willingness to test does not translate to readiness
to accept among the study participants. This reflects the
level of fear, anxiety and other emotional reactions asso-
ciated with anticipated positive HIV result [48]. The re-
actions to waiting for the result include being unable to
sleep, feeling very nervous and asking themselves many
questions about the possibilities. This finding is similar
to findings from Lazarus et al. [40]. Few participants
were curious to know the result of their children if they
were to be tested immediately, however, some lack cour-
age to see the result of their children. Previous studies
highlighted that significant proportion of mothers do
not return for results of PCR [20, 21]. Therefore, a point
of care PCR or other diagnostic modalities may provide
proof of concept on universal coverage of EID.
Universal coverage of EID among HIV-exposed infants
could be achieved if PCR test could be offered to all in-
fants at immunization clinics and at households, however,
the participants in this study had personal reservations at
recommending the test to other children in their commu-
nity. Despite the high prevalence of HIV in South Africa
[49] and the efforts of all stakeholders to reduce stigma
against people living with HIV and AIDS, people still live
in fear of being stigmatised if their infants were diagnosed
with HIV. More efforts are needed to eradicate HIV/AIDS
related stigma especially in the rural communities.
Strength and limitations of the study
The qualitative design of the study does not allow for
generalization of findings to other populations. However,
multiple primary healthcare centres and triangulation of
qualitative data gave credibility to the findings from the
study. The understanding of the challenges of EID in the
rural health facilities and communities in South Africa
might inform future policies and innovative strategies on
the expansion of access to EID. Future studies should
explore the health providers’ and health authorities’ per-
spectives on EID in South Africa.
Public health perspectives and clinical implications
The study highlights the challenges of universal coverage
of early infant diagnosis in the rural South Africa. The
understanding of these challenges might provide
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valuable input in designing effective programmatic strat-
egies towards universal coverage of early infant diagno-
sis. Health authorities should focus on incorporating
EID training into PMTCT counselling sessions at the
antenatal period. PMTCT counsellors and NIMART
trained nurses should be trained sufficiently in EID. This
will prepare mothers toward accessing the EID after de-
livery. Community education on infant HIV infection
could reduce stigma towards mothers of HIV-infected
infants.
Conclusion
Majority of the participants have good knowledge of HIV
infection in infants. However, some of them have some
misconceptions about MTCT. The knowledge of early in-
fant HIV diagnosis and early intervention with ARVs is
lacking among the participants. There is a mixed attitude
to early infant diagnosis: while some people were willing to
carry out EID others lack the courage to test their infants.
Fear, guilt, self-blame, hopelessness and embarrassment
were some of the reactions expressed towards positive
PCR result of their infants. Perceived fear of stigma within
the community affects access to early infant diagnosis in
these rural communities. Patient empowerment, improved
training of counsellors on EID and strengthening of health
systems are urgently needed to ensure universal coverage
of EID in the country.
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